Abbonarsi

Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative - 01/10/24

Doi : 10.1016/j.jbspin.2024.105733 
Adeline Ruyssen-Witrand a, , Damien Caillet-Portillo b, Aurélie Najm c, Olivier Fogel d, Athan Baillet e, Pascal Claudepierre f, Orenella Conort g, Emmanuelle Dernis h, Françoise Fayet i, Laure Gossec j, Philippe Goupille k, Christophe Hudry l, Jean-Guillaume Letarouilly m, Cédric Lukas n, Hubert Marotte o, Anna Molto p, Sophie Pouplin q, Eric Senbel r, Christelle Sordet s, Anne Tournadre t, Marie-Elise Truchetet u, v, Daniel Wendling w, Maxime Dougados x
a Rheumatology Centre, Toulouse University Hospital, Centre d’Investigation Clinique de Toulouse (CIC1436), Inserm, Team PEPSS “Pharmacologie En Population cohorteS et biobanqueS”, University of Toulouse 3, Toulouse, France 
b Rheumatology Centre, Toulouse University Hospital, University of Toulouse 3, Toulouse, France 
c Institute of Infection and Immunity, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom 
d Department of Rheumatology, Hôpital Cochin, Assistance publique–Hôpitaux de Paris, Paris, France 
e Université Grenoble-Alpes, TIMC, CNRS UMR5525, Grenoble, France 
f AP–HP, Service de Rhumatologie, Hôpital Henri-Mondor, Université Paris Est Créteil, EA 7379, EpiDermE, Paris, France 
g Department Clinical Pharmacy, Hôpital Cochin, Assistance publique–Hôpitaux de Paris, Paris, France 
h Department of Rheumatology and Clinical Immunology, General hospital Le Mans, Le Mans, France 
i Rheumatology Centre, Clermont University Hospital, Clermont-Ferrand, France 
j Sorbonne Université, Inserm, Institut Pierre-Louis d’Épidémiologie et de Santé Publique, AP–HP, Pitié-Salpêtrière Hospital, Rheumatology Department, Paris, France 
k Université de Tours, EA 6295, Department of Rheumatology, University Hospital of Tours, Tours, France 
l Institut Mutualiste Montsouris, Paris, France 
m University of Lille, CHU de Lille, FHU PRECISE, Rheumatology Department, Lille, France 
n Department of Rheumatology, University Hospital of Montpellier, Inserm UA11 (IDESP), University of Montpellier, Montpellier, France 
o Université Jean-Monnet Saint-Étienne, CHU de Saint-Étienne, Service de Rhumatologie, Mines Saint-Étienne, Inserm, SAINBIOSE U1059, 42023 Saint-Étienne, France 
p ECAMO team (Inserm U1153), Center of Research in Epidemiology and Statistics (CRESS), Université Paris-Cité, Paris, France 
q Rheumatology Centre, Rouen University Hospital, Rouen, France 
r Centre de Rhumatologie de l’Eldorado, Marseille, France 
s Rheumatology Center, Strasbourg University Hospital, University of Strasbourg, Strasbourg, France 
t Rheumatology Centre, Clermont University Hospital, UNH INRAe University Clermont Auvergne, Clermont-Ferrand, France 
u Department of Rheumatology, Hôpital Pellegrin, Bordeaux, France 
v Bordeaux University, CNRS, ImmunoConcept, UMR 5164, 33000 Bordeaux, France 
w Rheumatology Centre, CHU de Besançon, University Hospital, EA4266, Université de Franche-Comté, Besançon, France 
x University of Paris-Cité, Department of Rheumatology, Hôpital Cochin, Assistance publique–Hôpitaux de Paris, Inserm (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris, France 

Corresponding author. Rheumatology Center, Purpan Teaching Hospital, 1, place du Dr-Baylac, 31059 Toulouse cedex 9, France.Rheumatology Center, Purpan Teaching Hospital1, place du Dr-BaylacToulouse cedex 931059France

Highlights

An annual review of patients with axial spondyloarthritis encompassing disease activity, severity, comorbidities, employment, psychological factors, and lifestyle is recommended.
The specific content of this annual review has never been proposed.
This initiative provided a reporting framework including all components needing to be assessed during this review.
This document was obtained after a literature search and an expert consensus-driven approach.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Introduction

National and international scientific societies advocate for a regular, systematic, and standardized global evaluation of axial spondyloarthritis (axSpA) patients. However, there are no recommendations specifying the content of this global evaluation. This initiative aimed to propose a standardized reporting framework, using evidence-based and consensus approaches, to collect data on all domains of axSpA.

Methods

A literature review and consensus process involved a steering committee and an expert panel of 37 rheumatologists and health professionals. The first steering committee took place in March 2022 and identified the main domains for inclusion in the standardized report. A hierarchical literature review was conducted to identify items within these domains and tools for assessment. The items and tools for assessment were discussed and consensus was reached through a vote session during an expert meeting that took place in March 2023.

Results

The steering committee identified four main domains to include in the standardized reporting framework: disease assessment, comorbidities, lifestyle, and quality of life. Items and tools for assessment were adopted after the expert meeting. Additionally, recommendations regarding digital tools (websites, apps, social media) were provided.

Conclusion

This initiative led to a consensus, based on evidence and expertise, on a reporting framework for use during periodic systematic global evaluations of axSpa in daily practice.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Spondyloarthritis, Disease assessment, Comorbidities, Quality of life, E-health


Mappa


© 2024  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 91 - N° 5

Articolo 105733- settembre 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Proton pump inhibitors, bone and phosphocalcic metabolism
  • Cécile Philippoteaux, Julien Paccou, Emmanuel Chazard, Bernard Cortet
| Articolo seguente Articolo seguente
  • Clinical spectrum and outcome of Takayasu's arteritis in children
  • Nolan Hassold, Perrine Dusser, Audrey Laurent, Irene Lemelle, Pascal Pillet, Cloé Comarmond, Arsene Mekinian, Marc Lambert, Tristan Mirault, Ygal Benhamou, Alexandre Belot, Eric Jeziorski, Héloïse Reumaux, Jean Sibilia, Alexandra Desdoits, Olivier Espitia, Albert Faye, Pierre Quartier, David Saadoun, Isabelle Koné-Paut

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.